retatrutide research study phase 2 trial type 2 diabetes results 2024 There are many great studies to Effects of retatrutide on body – Retatrutide Phase 1 Trials |

Pharmaceutical trials exclude pregnant and nursing participants for ethical reasons, leaving lactation-specific data sparse

Tirzepatide, a dual GIP/GLP-1 receptor agonist, has even more limited reproductive safety data since it is newer than semaglutide

Its crucial to ensure that the benefits outweigh the risks over extended use

The central orange oval labeled GLP-1 connects by arrows to three benefits: glucose control (gut and glucose meter icon), weight loss (scale icon), and cardiovascular benefits (heart icon)

Think of a rusty car

The drug companies offer some coupons to help reduce the cost of the drugs for people without insurance coverage